IN2012DN01232A - - Google Patents
Download PDFInfo
- Publication number
- IN2012DN01232A IN2012DN01232A IN1232DEN2012A IN2012DN01232A IN 2012DN01232 A IN2012DN01232 A IN 2012DN01232A IN 1232DEN2012 A IN1232DEN2012 A IN 1232DEN2012A IN 2012DN01232 A IN2012DN01232 A IN 2012DN01232A
- Authority
- IN
- India
- Prior art keywords
- compounds
- formula
- well
- pharmaceutically acceptable
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/92—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with a hetero atom directly attached to the ring nitrogen atom
- C07D211/96—Sulfur atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Abstract
Compounds of formula (I) as well as pharmaceutically acceptable salts thereof can be used in the form of pharmaceutical compositions, wherein A1, A2, R1 ,R2, R3 ,R4, R5 and R6 have the significance given in claim 1.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP09170071 | 2009-09-11 | ||
PCT/EP2010/063078 WO2011029808A1 (en) | 2009-09-11 | 2010-09-07 | Hsl inhibitors useful in the treatment of diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2012DN01232A true IN2012DN01232A (en) | 2015-05-15 |
Family
ID=42983383
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN1232DEN2012 IN2012DN01232A (en) | 2009-09-11 | 2010-09-07 |
Country Status (17)
Country | Link |
---|---|
US (1) | US8258158B2 (en) |
EP (1) | EP2475644B1 (en) |
JP (1) | JP5642793B2 (en) |
KR (1) | KR101369551B1 (en) |
CN (1) | CN102498099B (en) |
AR (1) | AR078351A1 (en) |
AU (1) | AU2010294326A1 (en) |
BR (1) | BR112012005140A2 (en) |
CA (1) | CA2771452A1 (en) |
ES (1) | ES2445166T3 (en) |
HK (1) | HK1169993A1 (en) |
IL (1) | IL217966A0 (en) |
IN (1) | IN2012DN01232A (en) |
MX (1) | MX2012002597A (en) |
SG (1) | SG179031A1 (en) |
TW (1) | TW201114744A (en) |
WO (1) | WO2011029808A1 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR112013023924A2 (en) | 2011-03-18 | 2016-08-09 | Bayer Ip Gmbh | new halogen substituted compounds |
US9469631B2 (en) | 2012-09-10 | 2016-10-18 | Boehringer Ingelheim International Gmbh | N-cyclopropyl-N-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof |
WO2018104220A1 (en) * | 2016-12-09 | 2018-06-14 | Boehringer Ingelheim International Gmbh | Sulfonamides as inhibitors of the uptake of extracellular citrate |
GB2560713A (en) * | 2017-03-20 | 2018-09-26 | Eternygen Gmbh | Inhibitor of citrate transporter |
CN110003177B (en) * | 2019-05-28 | 2021-11-19 | 沈阳药科大学 | Benzimidazole compound containing carbamido and application thereof |
CN110003176B (en) * | 2019-05-28 | 2021-12-21 | 沈阳药科大学 | Amide-containing benzimidazole compound and application thereof |
GB201918410D0 (en) | 2019-12-13 | 2020-01-29 | Z Factor Ltd | Compounds and their use for the treatment of alpha1-antitrypsin deficiency |
WO2022130352A1 (en) * | 2020-12-19 | 2022-06-23 | Cadila Healthcare Limited | Novel compounds suitable for the treatment of dyslipidemia |
GB202108523D0 (en) | 2021-06-15 | 2021-07-28 | Z Factor Ltd | Compositions and their use for the treatment of alpha1-antitrypsin deficiency |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3779339B2 (en) | 1994-03-04 | 2006-05-24 | 三井化学株式会社 | Fluorine-containing carboxylic acid ester compound, liquid crystal material, liquid crystal composition, and liquid crystal element |
AU4692399A (en) * | 1998-06-17 | 2000-01-05 | Du Pont Pharmaceuticals Company | Cyclic hydroxamic acids as metalloproteinase inhibitors |
US7071213B2 (en) | 2001-11-14 | 2006-07-04 | Schering Corporation | Cannabinoid receptor ligands |
WO2006094633A1 (en) * | 2005-03-03 | 2006-09-14 | F. Hoffman-La Roche Ag | 1- sulfonyl-pi perdine- 3 -carboxyl i c acid amide derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase for the treatment of type ii diabetes mellitus |
TW200806675A (en) * | 2006-01-30 | 2008-02-01 | Array Biopharma Inc | Heterobicyclic thiophene compounds and methods of use |
JP2009539937A (en) * | 2006-06-16 | 2009-11-19 | ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー | Pharmaceutical use of substituted piperidine carboxamides |
EP1958631A1 (en) | 2007-02-14 | 2008-08-20 | AEterna Zentaris GmbH | Novel triazole derivatives as ligands of G-protein coupled receptors |
US8324250B2 (en) * | 2009-03-19 | 2012-12-04 | Hoffmann-La Roche Inc. | Piperidine derivatives as NK3 receptor antagonists |
US8329904B2 (en) * | 2009-05-12 | 2012-12-11 | Hoffmann-La Roche Inc. | Azacyclic derivatives |
US8399676B2 (en) * | 2009-07-30 | 2013-03-19 | Hoffman-La Roche Inc. | Piperidine derivatives |
-
2010
- 2010-09-03 US US12/875,446 patent/US8258158B2/en not_active Expired - Fee Related
- 2010-09-07 SG SG2012016085A patent/SG179031A1/en unknown
- 2010-09-07 JP JP2012528339A patent/JP5642793B2/en not_active Expired - Fee Related
- 2010-09-07 CA CA2771452A patent/CA2771452A1/en not_active Abandoned
- 2010-09-07 WO PCT/EP2010/063078 patent/WO2011029808A1/en active Application Filing
- 2010-09-07 CN CN201080039803.8A patent/CN102498099B/en not_active Expired - Fee Related
- 2010-09-07 ES ES10751931.6T patent/ES2445166T3/en active Active
- 2010-09-07 KR KR1020127009254A patent/KR101369551B1/en not_active IP Right Cessation
- 2010-09-07 BR BR112012005140A patent/BR112012005140A2/en not_active Application Discontinuation
- 2010-09-07 IN IN1232DEN2012 patent/IN2012DN01232A/en unknown
- 2010-09-07 EP EP10751931.6A patent/EP2475644B1/en not_active Not-in-force
- 2010-09-07 AU AU2010294326A patent/AU2010294326A1/en not_active Abandoned
- 2010-09-07 MX MX2012002597A patent/MX2012002597A/en active IP Right Grant
- 2010-09-08 TW TW099130350A patent/TW201114744A/en unknown
- 2010-09-09 AR ARP100103302A patent/AR078351A1/en unknown
-
2012
- 2012-02-06 IL IL217966A patent/IL217966A0/en unknown
- 2012-10-30 HK HK12110838.1A patent/HK1169993A1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
HK1169993A1 (en) | 2013-02-15 |
KR20120059617A (en) | 2012-06-08 |
KR101369551B1 (en) | 2014-03-04 |
SG179031A1 (en) | 2012-04-27 |
AU2010294326A1 (en) | 2012-03-08 |
AR078351A1 (en) | 2011-11-02 |
MX2012002597A (en) | 2012-04-02 |
EP2475644A1 (en) | 2012-07-18 |
WO2011029808A1 (en) | 2011-03-17 |
CA2771452A1 (en) | 2011-03-17 |
JP5642793B2 (en) | 2014-12-17 |
ES2445166T3 (en) | 2014-02-28 |
US8258158B2 (en) | 2012-09-04 |
TW201114744A (en) | 2011-05-01 |
JP2013504533A (en) | 2013-02-07 |
EP2475644B1 (en) | 2014-01-08 |
US20110065707A1 (en) | 2011-03-17 |
CN102498099B (en) | 2014-10-29 |
IL217966A0 (en) | 2012-03-29 |
CN102498099A (en) | 2012-06-13 |
BR112012005140A2 (en) | 2016-05-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2012DN03337A (en) | ||
IN2012DN01232A (en) | ||
MX2010005824A (en) | Aminothiazole derivatives. | |
MY138941A (en) | Aryl-pyridine derivatives | |
TW200738241A (en) | Pyridazine derivatives | |
UA108105C2 (en) | Nitrogen-containing heteroaryl compounds | |
MX2011012017A (en) | Azacyclic spiroderivatives as hsl inhibitors. | |
TW200626558A (en) | Indazolone derivatives | |
TW200616976A (en) | Pyrimidine derivatives | |
IN2012DN01233A (en) | ||
GEP20125487B (en) | Organic compounds and their use | |
TW200745032A (en) | Novel heterobicyclic derivatives | |
MX2009004441A (en) | Indazole derivatives useful as l-cpt1 inhibitors. | |
TW200738655A (en) | Novel bicyclic sulfonamide derivatives | |
TW200833324A (en) | Sulfonamide derivatives | |
TW200740764A (en) | Pyrazolone derivatives | |
DE602006021539D1 (en) | Morpholine als 5ht2c-agonisten | |
MX2012007536A (en) | Nitrogen-containing heteroaryl derivatives. | |
UA109037C2 (en) | Triazolepyridins | |
MX2010009022A (en) | 16 alpha, 17 alpa-acetal glucocorticosteroidal derivatives and their use. | |
TW200616958A (en) | New alkyl-pyridines as 11-beta inhibitors for diabetes | |
IN2012DN00765A (en) | ||
MX2008016426A (en) | Alkyl-pyridazine derivatives as inhibitors of 11 beta hydroxysteroid dehydrogenase type 1(11b-hsd 1). | |
MX2010005714A (en) | Pyridine compounds. | |
MY183039A (en) | Pyridin-2-yl derivatives as immunomodulating agents |